Nathan R. Foster

Also affiliated with Mayo Clinic in Arizona, Mayo Clinic in Florida

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Association of tumor-infiltrating lymphocytes with survival depends on primary tumor sidedness in stage III colon cancers (NCCTG N0147) [Alliance]”.

Association of tumor-infiltrating lymphocytes with survival depends on primary tumor sidedness in stage III colon cancers (NCCTG N0147) [Alliance]

Annals of Oncology(2022)10.1016/j.annonc.2022.07.1942

N/A

1.1DataRank · unranked

27 citations

Nathan R. Foster, Hye‐Eun Lee, Q. Shi, Steven R. Alberts, Thomas C. Smyrk +2 more

A phase 2 study of MK‐2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104)

Cancer(2023)10.1002/cncr.35103

N/A

0.481DataRank · unranked

12 citations

Nathan R. Foster, Shyamprasad Deraje Vasudeva, Nora Katabi, Cristina R. Antonescu, Gary Patrick Frenette +4 more

Incidence of Brain Metastasis as First Event in Patients with Esophageal Carcinoma: a Report from Three Prospective Alliance Clinical Trials

Journal of Gastrointestinal Cancer(2022)10.1007/s12029-022-00871-7

N/A

0.163DataRank · unranked

1 citations

Nathan R. Foster, Aminah Jatoi, Stephan D. Thomé, Robert C. Miller, Ron S. Smith

Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon Cancer

JNCI Cancer Spectrum(2021)10.1093/jncics/pkab070

N/A

0DataRank · unranked

9 citations

Qian Shi, Thomas C. Smyrk, Richard M. Goldberg, Steven J. Cohen, Sharlene Gill +9 more

Phase IB study of sorafenib and evofosfamide in patients with advanced hepatocellular and renal cell carcinomas (NCCTG N1135, Alliance)

Investigational New Drugs(2021)10.1007/s10637-021-01090-w

N/A

0DataRank · unranked

10 citations

Nathan R. Foster, Amit Mahipal, Thomas Byrne, Joleen M. Hubbard, Alvin Silva +4 more

Randomized phase II study of sorafenib with or without everolimus in patients with radioactive iodine refractory Hürthle cell thyroid cancer (HCC) (Alliance A091302/ ITOG 1706).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6076

N/A

0DataRank · unranked

13 citations

Nathan R. Foster, Yungpo Bernard Su, Ardaman Shergill, Alan L. Ho, Bhavana Konda +4 more

Association of plasma adiponectin with tumor infiltrating lymphocytes and survival in patients with stage III colon cancer (NCCTG N0147; Alliance).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.3591

N/A

0DataRank · unranked

1 citations

Qian Shi, Thomas C. Smyrk, Richard M. Goldberg, Steven J. Cohen, Sharlene Gill +9 more

Incidence of Brain Metastasis as First Event in Patients with Esophageal Carcinoma: A Report from Three Prospective Alliance Clinical Trials

Research Square(2022)10.21203/rs.3.rs-1815992/v1

N/A

0DataRank · unranked

1 citations

Nathan R. Foster, Aminah Jatoi, Stephan D. Thomé, Robert C. Miller, Ron S. Smith

Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps8598

N/A

0DataRank · unranked

1 citations

Austin W. Goodrich, Nathan R. Foster, Vinicius Ernani, Patrick M. Forde, Liza C. Villaruz +12 more

Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps8603

N/A

0DataRank · unranked

1 citations

Austin W. Goodrich, Nathan R. Foster, Panos Savvides, Liza C. Villaruz, Patrick M. Forde +12 more

Iron Deficiency in Collegiate Athletes Obtaining Preparticipation Hemoglobinopathy Screening in the Upper Midwest

Pediatric Blood & Cancer(2024)10.1002/pbc.31437

N/A

0DataRank · unranked

1 citations

Eugenia Trushina, DeLisa Fairweather, Darci R Block, Zhen Wang, Nathan R. Foster +4 more

Tumor-infiltrating lymphocytes and tumor budding refine prognostication in patients with low- and high-risk stage III colon cancers (NCCTG N0147)[Alliance].

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4065

N/A

0DataRank · unranked

0 citations

Hee Eun Lee, Nathan R. Foster, Qian Shi, Steven R. Alberts, Thomas C. Smyrk +2 more

A Multicenter Pilot Study of MUC1 Vaccine in Current and Former Smokers at High Risk for Lung Cancer

medRxiv(2025)10.1101/2025.06.25.25328823

N/A

0DataRank · unranked

0 citations

David E. Midthun, Małgorzata Wójtowicz, Julie Ward, Judy Forster, Tami Krpata +18 more

Prognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon Cancer

UNC Libraries(2020)10.17615/1ee6-h138

N/A

0DataRank · unranked

0 citations

Lois E. Shepherd, Amy J. French, Brian Kabat, Harold E. Windschitl, Stephen N. Thibodeau +4 more

Long-Term Results for MC1273, A Phase II Evaluation of De-Escalated Adjuvant Radiation Therapy for Human Papillomavirus Associated Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC)

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.07.155

N/A

0DataRank · unranked

15 citations

Katharine A. Price, M.J. Eric, Samir H. Patel, M.L. Hinni, Brenda Ginos +13 more